These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21051164)

  • 1. [Subsidized artemisinin based combination treatments for Africa].
    Fandeur T; Abani M
    Med Mal Infect; 2010 Nov; 40(11):611-6. PubMed ID: 21051164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Combined antimalarial therapy using artemisinin].
    Majori G
    Parassitologia; 2004 Jun; 46(1-2):85-7. PubMed ID: 15305693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of the Affordable Medicines for Malaria Facility (AMFm) in Ghana: processes, challenges and achievements.
    Malm KL; Segbaya S; Forson I; Gakpey KD; Sampong LB; Adjei EA; Bart-Plange C
    J Public Health Policy; 2013 May; 34(2):302-14. PubMed ID: 23575513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the Affordable Medicines Facility--malaria (AMFm) on the availability, price, and market share of quality-assured artemisinin-based combination therapies in seven countries: a before-and-after analysis of outlet survey data.
    Tougher S; ; Ye Y; Amuasi JH; Kourgueni IA; Thomson R; Goodman C; Mann AG; Ren R; Willey BA; Adegoke CA; Amin A; Ansong D; Bruxvoort K; Diallo DA; Diap G; Festo C; Johanes B; Juma E; Kalolella A; Malam O; Mberu B; Ndiaye S; Nguah SB; Seydou M; Taylor M; Rueda ST; Wamukoya M; Arnold F; Hanson K
    Lancet; 2012 Dec; 380(9857):1916-26. PubMed ID: 23122217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Access to subsidized ACT and malaria treatment--evidence from the first year of the AMFm program in six districts in Uganda.
    Fink G; Dickens WT; Jordan M; Cohen JL
    Health Policy Plan; 2014 Jul; 29(4):517-27. PubMed ID: 23783833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artemisinin-based combination therapies (ACTs): best hope for malaria treatment but inaccessible to the needy!
    Mutabingwa TK
    Acta Trop; 2005 Sep; 95(3):305-15. PubMed ID: 16098946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What happened to anti-malarial markets after the Affordable Medicines Facility-malaria pilot? Trends in ACT availability, price and market share from five African countries under continuation of the private sector co-payment mechanism.
    ; Tougher S; Hanson K; Goodman C
    Malar J; 2017 Apr; 16(1):173. PubMed ID: 28441956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Affordable Medicines Facility-malaria--a success in peril.
    Talisuna AO; Adibaku S; Amojah CN; Amofah GK; Aubyn V; Dodoo A; Juma E; Jackou DH; Mkude S; Okui AP; Ramarosandratana B; Shija SJ
    Malar J; 2012 Nov; 11():370. PubMed ID: 23137141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards subsidized malaria rapid diagnostic tests. Lessons learned from programmes to subsidise artemisinin-based combination therapies in the private sector: a review.
    Lussiana C
    Health Policy Plan; 2016 Sep; 31(7):928-39. PubMed ID: 25862732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in availability and prices of subsidized ACT over the first year of the AMFm: evidence from remote regions of Tanzania.
    Yadav P; Cohen JL; Alphs S; Arkedis J; Larson PS; Massaga J; Sabot O
    Malar J; 2012 Aug; 11():299. PubMed ID: 22929587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do price subsidies on artemisinin combination therapy for malaria increase household use? Evidence from a repeated cross-sectional study in remote regions of Tanzania.
    Cohen JL; Yadav P; Moucheraud C; Alphs S; Larson PS; Arkedis J; Massaga J; Sabot O
    PLoS One; 2013; 8(7):e70713. PubMed ID: 23923018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in the availability and affordability of subsidised artemisinin combination therapy in the private drug retail sector in rural Ghana: before and after the introduction of the AMFm subsidy.
    Ansah EK; Whitty CJ; Bart-Plange C; Gyapong M
    Int Health; 2016 Nov; 8(6):427-432. PubMed ID: 27744327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating antimalarial drugs consumption in Africa before the switch to artemisinin-based combination therapies (ACTs).
    Kindermans JM; Vandenbergh D; Vreeke E; Olliaro P; D'Altilia JP
    Malar J; 2007 Jul; 6():91. PubMed ID: 17623092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of introducing subsidized combination treatment with artemether-lumefantrine on sales of anti-malarial monotherapies: a survey of private sector pharmacies in Huambo, Angola.
    Lussiana C; Floridia M; Martinho do Rosário J; Fortes F; Allan R
    Trans R Soc Trop Med Hyg; 2016 Dec; 110(10):588-596. PubMed ID: 27856948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimalarial drug resistance in Africa: key lessons for the future.
    Takala-Harrison S; Laufer MK
    Ann N Y Acad Sci; 2015 Apr; 1342():62-7. PubMed ID: 25891142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The quest for universal access to effective malaria treatment: how can the AMFm contribute?
    Matowe L; Adeyi O
    Malar J; 2010 Oct; 9():274. PubMed ID: 20932286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving access to malaria medicine through private-sector subsidies in seven African countries.
    Tougher S; Mann AG; ; Ye Y; Kourgueni IA; Thomson R; Amuasi JH; Ren R; Willey BA; Ansong D; Bruxvoort K; Diap G; Festo C; Johanes B; Kalolella A; Mallam O; Mberu B; Ndiaye S; Nguah SB; Seydou M; Taylor M; Wamukoya M; Arnold F; Hanson K; Goodman C
    Health Aff (Millwood); 2014 Sep; 33(9):1576-85. PubMed ID: 25201662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A major transition in malaria treatment: the adoption and deployment of artemisinin-based combination therapies.
    Bosman A; Mendis KN
    Am J Trop Med Hyg; 2007 Dec; 77(6 Suppl):193-7. PubMed ID: 18165492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artemisinin-based combination therapy availability and use in the private sector of five AMFm phase 1 countries.
    Davis B; Ladner J; Sams K; Tekinturhan E; de Korte D; Saba J
    Malar J; 2013 Apr; 12():135. PubMed ID: 23607504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights following change in drug policy: a descriptive study for antimalarial prescription practices in children of public sector health facilities in Jharkhand state of India.
    Mishra N; Gupta R; Singh S; Rana R; Shahi B; Das MK; Anvikar AR; Valecha N
    J Vector Borne Dis; 2013 Dec; 50(4):271-7. PubMed ID: 24499849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.